For comments, suggestions
Created with Raphaël 2.1.0 13.08.2020 Filing date 11.03.2022 Validation fee payment 31.07.2022 (A1) Patent application published

Patent not validated (the request for validation was not submitted on time)


(210)Number of the EPO application20761961
(220)Filing date of the EPO application2020.08.13
(80)EPO patent specification publication (B)EPB nr. 16/2024, 2024.04.17
(110)EPO patent number4013741
(21)Number of the applicatione 2022 0694
(71)Name(s) of applicant(s), code of the countryVERTEX PHARMACEUTICALS INCORPORATED, US;
(72)Name(s) of inventor(s), code of the countryANGELL Paul, US;
COCHRAN John E., US;
LITTLER Benjamin J., US;
SIESEL David Andrew, US;
URBINA Armando, US;
ANDERSON Corey Don, US;
CLEMENS Jeremy J., US;
CLEVELAND Thomas, US;
COON Timothy Richard, US;
FRIEMAN Bryan, US;
GROOTENHUIS Peter, US;
HADIDA RUAH Sara Sabina, US;
MCCARTNEY Jason, US;
MILLER Mark Thomas, US;
PARASELLI Prasuna, US;
PIERRE Fabrice, US;
SWIFT Sara E., US;
ZHOU Jinglan, US;
(73)Name(s) of owner(s), code of the countryVERTEX PHARMACEUTICALS INCORPORATED, US;
(54)Title of the inventionPROCESS OF MAKING CFTR MODULATORS
(13)Kind-of-document code A1
(51)International Patent Classification C07D 207/08 (2006.01.01); C07D 207/09 (2006.01.01); C07D 213/61 (2006.01.01); C07D 213/62 (2006.01.01); C07D 213/70 (2006.01.01); C07D 213/74 (2006.01.01); C07D 231/20 (2006.01.01); C07D 401/04 (2006.01.01); C07D 401/14 (2006.01.01); C07D 513/22 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2022.07.31
(30)Priority201962886660 P, 2019.08.14, US
(86)International applicationPCT/US2020/046116, 2020.08.13
(87)International publicationWO 2021/030554, 2021.02.18
Up
/Inventions/details/4013741